Nanami Gotoh1, Takayuki Saitoh1, Rumi Ino1, Noriyuki Takahashi1, Tsukasa Oda2, Maaya Awata1, Rei Ishihara1, Masumi Ohata1, Yukihiro Kanai1, Keisuke Murata1, Yuki Murakami1, Saki Watanabe1, Tetsuhiro Kasamatsu1, Hiroaki Shimizu3, Makiko Takizawa3, Morio Matsumoto4, Morio Sawamura4, Akihiko Yokohama5, Norifumi Tsukamoto6, Hiroshi Handa3, Hirokazu Murakami1 (1.Graduate School of Health Sciences, Gunma University,Gunma,Japan, 2.Institute for Molecular and Cellular Regulation, Gunma University,Gunma,Japan, 3.Department of Hematology, Gunma University Graduate School of Medicine,Gunma,Japan, 4.Department of Hematology, National Hospital Organization, Shibukawa Medical Center,Gunma,Japan, 5.Division of Blood Transfusion Service, Gunma University Hospital,Gunma,Japan, 6.Oncology Center, Gunma University Hospital,Gunma,Japan)
Session information
Poster Session
Fri. Oct, 12
Poster Session 1-19 MM: Basic researches
Fri. Oct 12, 2018 5:30 PM - 6:10 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)
Chair: Satoshi Yoshihara (Transfusion Science and Celluler Therapy HYOGO COLLEGE OF MEDICENE)
Yuta Yamanaka, Tomoki Ito, Muneo Inaba, Yusuke Sawai, Yukie Tsubokura, Hideaki Yoshimura, Yoshiko Azuma, Minoru Shigesaka, Atsushi Satake, Shosaku Nomura (Kansai Medical Univ, Osaka, Japan)
Yusuke Sawai, Tomoki Ito, Muneo Inaba, Yuta Yamanaka, Yukie Tsubokura, Hideaki Yoshimura, Yoshiko Azuma, Minoru Shigesaka, Atsushi Satake, Shosaku Nomura (Kansai Medical Univ, Osaka, Japan)
Keima Ueda1, Mariko Ishibashi2, Hideto Tamura1, Yoichi Imai3, Hidemi Takahashi2, Koiti Inokuchi1 (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan, 3.Department of Hematology and Oncology, IMSUT Hospital, Tokyo, Japan)
Yasuhiro Kazuma1, Kotaro Shirakawa1, Hiroyuki Matsui1, Hiroyuki Yamazaki1, Tadahiko Matsumoto1, Shinji Ito2, Akifumi Takaori-Kondo1 (1.Dept. Hematol. Oncol., Kyoto Univ., Sch. Med., Kyoto, Japan, 2.Medical Research Support Center, Kyoto Univ., Sch. Med, Kyoto, Japan)
Soushi Ibata1,3, Yusuke Sugama1,2, Shohei Kikuchi1, Ayumi Tatekoshi1, Hiroshi Ikeda1, Kazuyuki Murase1,2, Koichi Takada1,2, Satoshi Iyama1, Junji Kato2, Masayoshi Kobune1 (1.Department of Hematology., Sappro Medical Univ., Sapporo, Japan, 2.Department of Medical Oncology., Sappro Medical Univ., Sapporo, Japan, 3.Department of Hematology and Oncology. Ohji general Hospital, Sapporo, Japan)
Mika Sunakawa1, Hideto Tamura1, Mariko Ishibashi2, Yuta Kaito1, Ryosuke Kinoshita1, Toshio Asayama1, Keiichi Moriya1, Hiroshi Handa3, Makoto Sasaki4, Yoichi Imai5, Norina Tanaka6, Shigeki Ito7, Sakae Tanosaki8, Junji Tanaka6, Norio Komatsu4, Koiti Inokuchi1 (1.Division of Hematology, Department of Medicine, Nippon Medical School, 2.Deptartment of Microbiology and Immunology, Nippon Medical School, 3.Department of Medicine and Clinical Science, Gunma University of Medicine, 4.Division of Hematology, Juntendo University of Medicine, 5.Department of Hematology, the University of Tokyo, 6.Department of Hematology, Tokyo Women's Medical University, 7.Department of Medical Oncology, Iwate Medical University School of Medicine, 8.Department of Hematology, Fraternity Memorial Hospital)
Yun-Chu Lin, Shang-Yi Huang, Yi-Fan Chen (Hematology, National Taiwan University Hospital, Taipei City, Taiwan)